Go to the list of all blogs
Alicia's Avatar
published in Blogs
Mar 02, 2026
(GE) Aerospace in a Hotter World: War, Defense Budgets, and the Stock’s Flight Path

(GE) Aerospace in a Hotter World: War, Defense Budgets, and the Stock’s Flight Path

GE Aerospace (GE) is already in a powerful uptrend, and the Iran war environment reinforces its defense and aftermarket story, so the bias for the stock is still up, but from stretched levels where gains are likely to be steadier and more volatile rather than parabolic.

GE Aerospace in a Hotter Geopolitical and Aviation Cycle

GE Aerospace is now a pure‑play aviation and defense company, with two main engines: commercial engines and services, and defense and propulsion technologies. It designs, manufactures, and services jet engines for commercial and business aviation, as well as engines and critical systems for military aircraft, and it earns most of its profits from decades‑long aftermarket service on a global installed base of nearly 80,000 engines. Revenue growth has been strong—Q3 revenue was up over 30% year over year in one recent quarter and about 17–18% year over year on a trailing basis—while net income has risen above 2 billion dollars per quarter and operating margins remain high teens, albeit under some pressure.

The market has rewarded this transformation: GE stock is up roughly 70–72% over the past 12 months, recently hit an all‑time high around 348–349 dollars, and now trades in the low‑ to mid‑340s with a market cap well above 350 billion dollars. The Iran war adds another layer of support. Defense and aerospace stocks have been in favor all year; the iShares U.S. Aerospace & Defense ETF is already up about 14% in 2026, and commentary points to prolonged conflict and readiness spending as a structural tailwind. For GE, this shows up both on the defense side (engines and systems for military aircraft, more flight hours, more maintenance) and indirectly on the commercial side, as airlines prioritize reliability, engine performance, and predictive maintenance to manage war‑driven disruptions and high fuel costs.

At the same time, valuation has become a front‑and‑center question. One detailed analysis notes that while GE’s fundamentals are strong, growth is expected to decelerate, core margins are tightening, and regulatory questions around flagship engines like LEAP are adding uncertainty. Another overview shows analysts expecting GE to post about 5.4 dollars in EPS this year and guiding to 7.10–7.40 dollars in EPS for 2026, which implies powerful earnings growth but also leaves the stock trading at a rich forward multiple. Sell‑side coverage is still very positive—one Strong Buy, 16 Buys, one Hold, and one Sell—with a consensus rating of “Moderate Buy” and an average price target around 329 dollars, even as several big banks have nudged targets up into the 335–380‑dollar range and some forecasts run as high as 374 dollars. That mix suggests the Street expects GE to remain in an uptrend, but with less room for error and more sensitivity to any negative surprise, including how the Iran conflict affects airline demand, fuel costs, or defense budgets at the margin.

Key Takeaways

  • GE Aerospace is a focused aviation and defense company with two major segments—commercial engines and services, and defense and propulsion—earning most of its profits from long‑duration engine service on an installed base near 80,000 engines.

  • Revenue and earnings growth have been strong, with recent quarterly revenue above 11 billion dollars, up high‑teens year over year, and net income over 2 billion dollars; management guides to 2026 EPS of 7.10–7.40 dollars, well above this year’s roughly 5.4‑dollar consensus.

  • The Iran war is boosting interest in aerospace and defense equities; sector ETFs are up double digits in 2026, and GE benefits from both higher defense demand and growing reliance on its engines and AI‑driven maintenance (“AI Wingmate”) as airlines navigate a riskier, more congested airspace environment.

  • GE shares have surged about 70–72% over the past year and recently hit an all‑time high near 348.48 dollars; they now trade in the low‑ to mid‑340s, with analysts’ average target around 329 dollars but several major firms lifting targets into the mid‑300s, and an overall “Moderate Buy” consensus.

  • This setup points to a stock still biased upward—supported by backlog, services growth, and war‑reinforced defense demand—but with valuation and growth‑deceleration worries capping easy upside, meaning investors should expect more volatility and dependence on execution rather than a simple “war = straight up” trade.

How Tickeron’s AI Tools Can Help With GE

AI platforms like Tickeron can help you navigate GE’s combination of momentum, rich valuation, and war‑driven sentiment. Pattern‑recognition engines can scan GE’s chart for breakouts near record highs, pullbacks to key moving averages, and volatility spikes around Iran‑related headlines or earnings, then backtest how similar setups behaved for GE and other aerospace names in prior cycles. Event‑driven models that track price, volume, options activity, and sector ETFs can flag when GE is over‑ or under‑reacting relative to the broader aerospace and defense basket, offering probability‑based scenarios for short‑term continuation or mean reversion rather than trades fueled purely by FOMO. Combined with fundamental signals—changes in 2026 EPS guidance, engine order announcements, regulatory developments, and shifts in analyst targets—Tickeron’s AI can help you decide whether to buy GE on dips within this uptrend, trim exposure into strength, or wait for better risk‑reward before entering a war‑driven, high‑expectation name.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: GE

GE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for GE turned positive on August 03, 2026. Looking at past instances where GE's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on GE as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GE advanced for three days, in of 367 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 395 cases where GE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GE moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GE broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.173) is normal, around the industry mean (10.705). P/E Ratio (44.491) is within average values for comparable stocks, (64.198). Projected Growth (PEG Ratio) (5.542) is also within normal values, averaging (8.304). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (7.868) is also within normal values, averaging (36.455).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.68B. The market cap for tickers in the group ranges from 4.49 to 1.65T. SPCX holds the highest valuation in this group at 1.65T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 8%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 7%. DFNS experienced the highest price growth at 97%, while VWAV experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was 0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 67
Price Growth Rating: 58
SMR Rating: 79
Profit Risk Rating: 72
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
GE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of products for the generation, transmission, distribution, control and utilization of electricity; manufactures aircraft engines and medical equipment

Industry AerospaceDefense

Profile
Details
Industry
Industrial Conglomerates
Address
One Financial Center
Phone
+1 617 443-3000
Employees
125000
Web
https://www.geaerospace.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.